SKI Market

A+| A| A-|

Indian Indices

Sensex

76,921.64 -548.47
( -0.71%)

Global Indices

Nasdaq

52,245.67 385.41
(0.74%)

Dow Jones

7,529.66 65.38
(0.88%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.43 0.01
(0.01%)

EUR-INR

110.17 -0.09
(-0.08%)

GBP-INR

129.67 0.03
(0.02%)

JPY-INR

0.59 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

-18.1148384

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

42.95

EPS(TTM)

Face Value()

Div & Yield %

Back

COSYN reports consolidated net profit of Rs 0.04 crore in the June 2026 quarter

Jul 18,2026

Net profit of COSYN remain constant at Rs 0.04 crore in the quarter ended June 2026 and also during the previous quarter ended June 2025. Sales rose 49.30% to Rs 1.06 crore in the quarter ended June 2026 as against Rs 0.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.06	0.71	49
OPM %	27.36	45.07	-
PBDT	0.22	0.25	-12
PBT	0.03	0.04	-25
NP	0.04	0.04	0

76,921.64 -548.47 ( -0.71%)

52,245.67 385.41 (0.74%)

7,529.66 65.38 (0.88%)

66,064.76 1,923.64 (3.00%)

10,580.59 55.83 (0.53%)

96.43 0.01 (0.01%)

110.17 -0.09 (-0.08%)

129.67 0.03 (0.02%)

0.59 0.00 (0.01%)